
ITVISMA is a treatment with no refills, no recurring injections, and no ongoing reauthorizations.* Just one dose designed to work continuously.
Dosing across spinal muscular atrophy (SMA) treatments for people 2 years of age and older†
Treatment | ITVISMA | SPINRAZA® (nusinersen) | EVRYSDI® (risdiplam) |
Dosing schedule | A single dose | 3x per year (after initial starting doses) | Once daily |
How it's given | Injected into | Injected into spine (intrathecal injection) | Orally as |
Be sure to talk to a doctor about detailed dosing information.
Picture what life could look like with a one-time dose of ITVISMA.
*Corticosteroids are required before and after treatment and may be administered orally (which may require refills and reauthorization) or via injection if oral corticosteroids are not tolerated or effective. Talk to your doctor.
†This chart is intended to show dosing information only and should not be considered a comparison of efficacy or safety.
EVRYSDI® is a registered trademark of Genentech USA, Inc.
SPINRAZA® is a registered trademark of Biogen.
